Miltefosine/Paromomycin Phase III Trial for Treatment of Primary Visceral Leishmaniasis (VL) Patients in Eastern Africa

NCT03129646 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

439

Enrollment

OTHER

Sponsor class

Conditions

Visceral Leishmaniasis

Interventions

DRUG: Miltefosine
DRUG: Paromomycin
DRUG: Sodium stibogluconate

Sponsor

Drugs for Neglected Diseases

Collaborators

[object Object]
[object Object]
[object Object]
[object Object]
[object Object]